Fabhalta 200 MG
Ended Awarded
- Contract number
- 36C24526N0191
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,838
Award facts
- Contract value 100% obligated
- $33,838.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $33.8K delivery order to Novartis Pharmaceuticals Corporation for FABHALTA 200 MG, a pharmaceutical product to be delivered to Cary, North Carolina. This firm fixed-price contract, awarded on December 16, 2025, with an ultimate completion date of December 19, 2025, was issued without a small business set-aside designation. The award falls under Novartis' existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract and represents a routine procurement of specialized pharmaceutical treatments for veterans.
Novartis Pharmaceuticals Corporation, a major foreign-owned pharmaceutical manufacturer headquartered in East Hanover, New Jersey, is an established federal contractor with the VA and other defense health agencies. The company primarily supplies innovative cancer therapies and specialized medical treatments to federal healthcare systems through firm fixed-price delivery orders, competing directly in the federal marketplace as a large pharmaceutical provider. This award reflects Novartis' ongoing partnership with the VA to provide critical pharmaceutical therapies to support the agency's patient care mission across its integrated service networks.
Quick answers
Who was awarded contract 36C24526N0191?
36C24526N0191 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 16, 2025.
How much is contract 36C24526N0191 worth?
The government has obligated $33,838 on 36C24526N0191.
Is contract 36C24526N0191 an order under another contract?
Yes. 36C24526N0191 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0191 competed?
The extent of competition for 36C24526N0191 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award